Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2014

Jan 3, 2014

34301_dirs_2014-01-03_9faf76b7-44ea-4737-a094-933ae0c7adb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2013-12-31

Reporting Person: RICKEY DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-01-01 Restricted Stock Award (Common Stock) A 10550 Acquired 10550 Direct
2013-12-31 Common Stock G 29519 Disposed 0 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-01-01 Non- Qualified Stock Option (Right to Buy) $2.57 A 16030 Acquired 2024-01-01 Common Stock (16030) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 211566 Indirect
Common Stock 115059 Indirect

Footnotes

F1: The Restricted Stock Award vests in full on January 2, 2015, subject to the terms of the Company's 2004 Equity Incentive Plan.

F2: This transaction is a gift of securities to Mr. Rickey's children.

F3: These securities are owned by David M. Rickey, Trustee FBO The Rickey Annuity Trust.

F4: The stock options vest 1/24th each month from date of grant, subject to the terms of the Company's 2004 Equity Incentive Plan.